Through a more detailed analysis of the association between CLDN18.2 and HER2 in STAD, we found that CLDN18.2 expression was significantly positively correlated with ERBB2 expression (P = 0.023) (Supplementary Figure S4A). Here, ERBB2 is linked to gastric adenocarcinoma.